blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3187175

EP3187175 - SUPPLEMENTARY THERAPEUTIC FORMULATIONS FOR THE SEQUENTIAL OR SEPARATE ADMINISTRATION OF BUTYRIC ACID AND PROBIOTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.02.2022
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  26.02.2021
FormerGrant of patent is intended
Status updated on  21.10.2020
FormerRequest for examination was made
Status updated on  05.01.2018
FormerThe application has been published
Status updated on  02.06.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Euro-Pharma S.r.l.
Via Garzigliana, 8
10127 Torino / IT
[2021/13]
Former [2017/27]For all designated states
Euro-Pharma S.r.l.
Via Garzigliana, 8
10127 Torino / IT
Inventor(s)01 / MISCIOSCIA, Mario
deceased / IT
 [2021/24]
Former [2017/27]01 / MISCIOSCIA, Mario
Via Garzigliana 8
10127 TORINO / IT
Representative(s)Coppo, Alessandro, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[2021/13]
Former [2017/27]Brighenti, Livio, et al
NOTARBARTOLO & GERVASI S.p.A. Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date16206400.022.12.2016
[2017/27]
Priority number, dateIT2015UB0913822.12.2015         Original published format: IT UB20159138
[2017/27]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3187175
Date:05.07.2017
Language:EN
[2017/27]
Type: B1 Patent specification 
No.:EP3187175
Date:31.03.2021
Language:EN
[2021/13]
Search report(s)(Supplementary) European search report - dispatched on:EP02.06.2017
ClassificationIPC:A61K31/19, A61K9/20, A61K9/48, A61K35/745, A61K9/16, A61K9/28, A61P1/00, A61K36/752
[2020/46]
CPC:
A61K9/2013 (EP); A23L33/105 (EP); A23L33/12 (EP);
A23L33/135 (EP); A23L33/21 (EP); A61K31/19 (EP);
A61K35/745 (EP); A61K35/747 (EP); A61K36/752 (EP);
A61K9/1664 (EP); A61K9/2866 (EP); A61K9/288 (EP);
A61K9/4858 (EP); A61P1/00 (EP); A23V2002/00 (EP) (-)
C-Set:
A61K31/19, A61K2300/00 (EP);
A61K36/752, A61K2300/00 (EP);
A23V2002/00, A23V2200/3202, A23V2200/3204, A23V2250/284 (EP)
Former IPC [2020/45]A61K9/20, A61K9/48, A61K35/745, A61K9/16, A61K9/28, A61P1/00
Former IPC [2017/27]A61K9/20, A61K9/48, A61K35/745, A61K9/16, A61K9/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/06]
Former [2017/27]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSÄTZLICHE THERAPEUTISCHE FORMULIERUNGEN ZUR SEQUENZIELLEN ODER SEPARATEN VERABREICHUNG VON BUTTERSÄURE UND PROBIOTIKA[2017/27]
English:SUPPLEMENTARY THERAPEUTIC FORMULATIONS FOR THE SEQUENTIAL OR SEPARATE ADMINISTRATION OF BUTYRIC ACID AND PROBIOTICS[2017/27]
French:FORMULATIONS THÉRAPEUTIQUES SUPPLÉMENTAIRES POUR L'ADMINISTRATION SÉQUENTIELLE OU SÉPARÉE D'ACIDE BUTYRIQUE ET PROBIOTIQUES[2017/27]
Examination procedure22.12.2016Date on which the examining division has become responsible
21.12.2017Amendment by applicant (claims and/or description)
21.12.2017Examination requested  [2018/06]
22.10.2020Communication of intention to grant the patent
22.02.2021Fee for grant paid
22.02.2021Fee for publishing/printing paid
22.02.2021Receipt of the translation of the claim(s)
Opposition(s)04.01.2022No opposition filed within time limit [2022/10]
Fees paidRenewal fee
21.12.2018Renewal fee patent year 03
31.12.2019Renewal fee patent year 04
31.12.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.12.2016
AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
MK31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
IE22.12.2021
LU22.12.2021
BE31.12.2021
[2024/22]
Former [2023/27]HU22.12.2016
AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
IE22.12.2021
LU22.12.2021
BE31.12.2021
Former [2023/01]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
IE22.12.2021
LU22.12.2021
BE31.12.2021
Former [2022/48]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
IE22.12.2021
LU22.12.2021
Former [2022/46]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
LU22.12.2021
Former [2022/33]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/29]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/23]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/10]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
PT02.08.2021
IS24.12.2021
Former [2022/08]AT31.03.2021
CZ31.03.2021
DK31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
Former [2021/51]AT31.03.2021
CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
IS31.07.2021
PT02.08.2021
Former [2021/50]AT31.03.2021
CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RO31.03.2021
RS31.03.2021
SE31.03.2021
SK31.03.2021
SM31.03.2021
NO30.06.2021
PT02.08.2021
Former [2021/48]AT31.03.2021
CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RS31.03.2021
SE31.03.2021
SM31.03.2021
NO30.06.2021
Former [2021/47]AT31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
NL31.03.2021
RS31.03.2021
SE31.03.2021
SM31.03.2021
NO30.06.2021
Former [2021/46]AT31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
RS31.03.2021
SE31.03.2021
SM31.03.2021
NO30.06.2021
Former [2021/38]FI31.03.2021
HR31.03.2021
LV31.03.2021
RS31.03.2021
SE31.03.2021
NO30.06.2021
Former [2021/37]FI31.03.2021
HR31.03.2021
LV31.03.2021
RS31.03.2021
NO30.06.2021
Former [2021/35]FI31.03.2021
HR31.03.2021
NO30.06.2021
Former [2021/33]FI31.03.2021
NO30.06.2021
Documents cited:Search[YA]EP1236466  (EFRAT BIOPOLYMERS LTD [IL]) [Y] 14 * paragraph [0084] * [A] 1-13;
 [YA]WO2005074718  (COSMO SPA [IT], et al) [Y] 14 * page 7, line 12 - line 19 * * example - * [A] 1-13;
 [A]WO2007125558  (ANIDRAL SRL [IT], et al) [A] 1-14 * page 1, line 1 - page 4, line 6 * * page 11, line 8 - page 17, line 17 * * page 21, line 5 - page 23, line 4 *;
 [YA]EP2289505  (ALPIFLOR S R L [IT]) [Y] 14 * the whole document * [A] 1-13;
 [YA]WO2012013495  (COSMO TECHNOLOGIES LTD [IE], et al) [Y] 14 * the whole document * [A] 1-13;
 [A]WO2014152338  (KABADI MOHAN [US], et al) [A] 1-14 * page 4, line 4 - line 18 * * page 36, line 14 - page 42, line 9 *;
 [YA]  - LEE TAE-HO ET AL, "The Inhibitory Effect of Grapefruit Seed Extracts on the Physiological Function of Enterobacter pyrinus", KOREAN JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, SEOUL, KR, (19951231), vol. 27, no. 6, ISSN 0367-6293, pages 985 - 990, XP053022952 [Y] 14 * the whole document * [A] 1-13
by applicantWO2013114185
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.